Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STOK | AZN | AMGN | GILD | GSK |
| Company | Stoke Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 34.26 | 206.60 | 372.01 | 150.58 | 59.87 |
| High | 35.39 | 207.69 | 377.00 | 153.26 | 60.05 |
| Low | 33.60 | 204.56 | 371.39 | 150.09 | 59.33 |
| Latest | 34.03 | 205.58 | 374.67 | 151.95 | 59.62 |
| Change | -0.34 | -0.87 | -0.83 | +0.83 | -0.75 |
| % Change | -0.99% | -0.42% | -0.22% | +0.55% | -1.24% |
| Volume | 300,942 | 988,544 | 1,192,308 | 2,660,460 | 3,517,354 |
| 20-Day Average Volume | 567,255 | 2,875,965 | 2,932,917 | 8,196,647 | 6,541,531 |
| Previous Close | 34.37 | 206.45 | 375.50 | 151.12 | 60.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.48 | 194.56 | 361.00 | 147.12 | 56.08 |
| 20-Day Raw Stochastic | 82.68% | 74.57% | 77.70% | 78.09% | 85.10% |
| 20-Day Relative Strength | 57.86 | 62.55 | 62.09 | 63.89 | 69.16 |
| Weighted Alpha | +255.52 | +47.10 | +32.32 | +48.18 | +74.88 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Buy | 64% Buy | 88% Buy | 96% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.37% since 02/12/26 | +0.30% since 02/12/26 | +2.30% since 02/12/26 | -0.18% since 02/12/26 | +2.05% since 02/12/26 |
| Low | 30.50 on 02/17/26 | 204.09 on 02/13/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 58.56 on 02/13/26 |
| High | 35.39 on 02/20/26 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 61.69 on 02/18/26 |
| 1-Month | |||||
| %Chg | +19.22% since 01/20/26 | +14.03% since 01/20/26 | +13.18% since 01/20/26 | +22.06% since 01/20/26 | +25.37% since 01/20/26 |
| Low | 28.45 on 01/21/26 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 47.77 on 01/21/26 |
| High | 35.39 on 02/20/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 3-Month | |||||
| %Chg | +22.59% since 11/20/25 | +15.65% since 11/20/25 | +11.47% since 11/20/25 | +21.23% since 11/20/25 | +29.56% since 11/20/25 |
| Low | 25.21 on 01/12/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 46.47 on 11/21/25 |
| High | 37.34 on 01/07/26 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | +77.23% since 08/20/25 | +27.38% since 08/20/25 | +26.37% since 08/20/25 | +27.63% since 08/20/25 | +49.09% since 08/20/25 |
| Low | 18.00 on 08/26/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 |
| High | 38.69 on 10/16/25 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,963,111 | 323,550,432 | 202,420,032 | 187,491,552 | 124,037,000 |
| Shares Outstanding, K | 57,117 | 1,550,908 | 539,068 | 1,240,680 | 2,038,406 |
| Annual Sales | 36,560,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -88,980,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 10,630,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,464,090,000 |
| Last Quarter Net Income | -38,350,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 846,040,000 |
| 60-Month Beta | 1.10 | 0.34 | 0.46 | 0.36 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 |
| Latest Earnings Date | 03/17/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.478 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 46.24 | 25.76 | 17.38 | 18.74 | 13.54 |